Advancing Sleep Medicine: New FDA-Approved Treatments and Updated Guidelines

Written By Dr. Jyotsana Shree and Reviewed by Dr. Manvir Bhatia-07/04/2025. Sleep disorders significantly impact millions of individuals worldwide, affecting overall health, cognitive function, and quality of life. Recent FDA approvals have introduced groundbreaking therapies that are transforming the management of obstructive sleep apnea (OSA), narcolepsy, restless legs syndrome (RLS), and idiopathic hypersomnia (IH). This…

Read More

Look out for the signs of Hypersomnia to avoid the impaired quality of life

December 22nd, 2021|| Hypersomnia Hypersomnia is a condition wherein the person either suffers from excessive daytime sleepiness (EDS) or spends excessive time sleeping. It is characterized by prolonged nighttime sleep and recurrent episodes of sleepiness during the daytime. The individual suffers from an uncontrolled need to take a nap at inappropriate times such as during…

Read More

Sleep Update 2018 Organised by Dr.Manvir Bhatia and Dr.Preeti Devnani on 22nd April at IIT New Delhi

Sleep Update 2018 was conducted on 22nd April 2018 by Dr.Manvir Bhatia and Dr.Preeti Devnani at IIT New Delhi with a theme “Current Guideline & Quality of care in Sleep Medicine”. There were 70 delegates who attended this conference. The Conference was divided into 4 Symposia. Symposia-1 Highlighted the treatment, investigate modalities used for OSA….

Read More
Translate »